ArticleScientific reports2025
Quality of life among patients with multiple sclerosis: association with disease acceptance, optimism, and health-promoting behaviors.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Big Picture: 26 Years of Longitudinal Findings About Health Promotion and Quality of Life in Multiple Sclerosis.Healthcare (Basel, Switzerland) · 2026Review
- Health behaviors and symptom clusters mediate self-management efficacy and quality of life in lung cancer immunotherapy.Scientific reports · 2026Article
- Parallel Mediating Roles of Illness Acceptance Attitudes Between Physical Symptoms and Quality of Life in Patients with Gastrointestinal Cancers.Current medical science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple sclerosis (MS) is a chronic, progressive disease of the central nervous system, primarily affecting individuals in early adulthood and serving as a leading cause of disability among young adults. Despite advancements in understanding its etiology, there is currently no cure for MS. The disease's unpredictability, progression, and associated symptoms can significantly impair patients' daily, familial, social, and professional functioning, thereby substantially diminishing their quality of life. This study aimed to evaluate the quality of life (QoL) in patients with MS and its association with optimism, disease acceptance, and health-promoting behaviors. The study was conducted among 101 MS patients (mean age of 40.55 years). It utilized a questionnaire designed by the authors, encompassing sociodemographic and clinical data, as well as standardized instruments: the Revised Life Orientation Test (LOT-R), Health Behavior Inventory (HBI), Acceptance of Illness Scale (AIS), and Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL). Data analysis revealed that: The average QoL score on the MusiQoL scale was 69.33 out of 100. Respondents' optimism was at a moderate level and significantly correlated with higher QoL. The average score for health-promoting behaviors was 84.2, with a positive psychological attitude showing the strongest association with improved QoL. The level of disease acceptance among MS patients was moderate, averaging 29.84 out of 40 points. Increased disease acceptance significantly enhanced respondents' QoL. Higher levels of disease acceptance and optimism positively influence QoL in MS patients. Health-promoting behaviors are significantly correlated with various QoL domains in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.